These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9620722)

  • 1. Failure of co-trimoxazole in Pneumocystis carinii infection and mutations in dihydropteroate synthase gene.
    Mei Q; Gurunathan S; Masur H; Kovacs JA
    Lancet; 1998 May; 351(9116):1631-2. PubMed ID: 9620722
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-resistant Pneumocystis carinii.
    Meshnick SR
    Lancet; 1999 Oct; 354(9187):1318-9. PubMed ID: 10533856
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P carinii pneumonia in patients with HIV-1: a prospective study.
    Navin TR; Beard CB; Huang L; del Rio C; Lee S; Pieniazek NJ; Carter JL; Le T; Hightower A; Rimland D
    Lancet; 2001 Aug; 358(9281):545-9. PubMed ID: 11520525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use.
    Ma L; Borio L; Masur H; Kovacs JA
    J Infect Dis; 1999 Dec; 180(6):1969-78. PubMed ID: 10558954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients.
    Kazanjian P; Locke AB; Hossler PA; Lane BR; Bartlett MS; Smith JW; Cannon M; Meshnick SR
    AIDS; 1998 May; 12(8):873-8. PubMed ID: 9631140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of dihydropteroate synthase gene typing for Pneumocystis carinii f.sp. hominis epidemiology.
    Santos LD; Lacube P; Latouche S; Kac G; Mayaud C; Marteau M; Poirot JL; Maury E; Guillot J; Roux P
    J Eukaryot Microbiol; 1999; 46(5):133S-134S. PubMed ID: 10519287
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial response: Prophylaxis for Pneumocystis carinii pneumonia--an evolving tale of two populations.
    Gaut P; Daar ES
    Clin Infect Dis; 1999 Oct; 29(4):784-6. PubMed ID: 10589888
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship between mutations in dihydropteroate synthase of Pneumocystis carinii f. sp. hominis isolates in Japan and resistance to sulfonamide therapy.
    Takahashi T; Hosoya N; Endo T; Nakamura T; Sakashita H; Kimura K; Ohnishi K; Nakamura Y; Iwamoto A
    J Clin Microbiol; 2000 Sep; 38(9):3161-4. PubMed ID: 10970350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PCR-RFLP analysis of the DHPS gene for the study of resistance of Pneumocystis carinii to sulpha drugs in patients with co-infection PCP/HIV.
    Costa MC; Helweg-Larsen J; Antunes F; Lungren B; Diogo J; Matos O
    J Eukaryot Microbiol; 2001; Suppl():148S-149S. PubMed ID: 11906035
    [No Abstract]   [Full Text] [Related]  

  • 10. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in immunocompromised patients.
    Armstrong W; Meshnick S; Kazanjian P
    Microbes Infect; 2000 Jan; 2(1):61-7. PubMed ID: 10717542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumocystis carinii dihydropteroate synthase mutations and treatment with sulfa or sulfone regimens: a proposal for standardized definitions for clinical evaluation.
    Huang L; Morris AM; Beard CB
    J Eukaryot Microbiol; 2001; Suppl():180S-181S. PubMed ID: 11906054
    [No Abstract]   [Full Text] [Related]  

  • 12. Mutations in the dihydropteroate synthase gene of human-derived Pneumocystis carinii isolates from Italy are infrequent but correlate with prior sulfa prophylaxis.
    Ma L; Kovacs JA; Cargnel A; Valerio A; Fantoni G; Atzori C
    J Infect Dis; 2002 May; 185(10):1530-2. PubMed ID: 11992293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discontinuing prophylaxis against Pneumocystis carinii pneumonia.
    Bender MA; Sax PE
    N Engl J Med; 2001 May; 344(21):1639; author reply 1640-1. PubMed ID: 11374364
    [No Abstract]   [Full Text] [Related]  

  • 14. Prophylaxis against Pneumocystis carinii pneumonia for HIV-exposed infants in Africa.
    Graham SM
    Lancet; 2002 Dec; 360(9349):1966-8. PubMed ID: 12493279
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia.
    Helweg-Larsen J; Benfield TL; Eugen-Olsen J; Lundgren JD; Lundgren B
    Lancet; 1999 Oct; 354(9187):1347-51. PubMed ID: 10533864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumocystis jiroveci pneumonia in AIDS patients: reactivation, reinfection or both?
    Hudson CP; Roach TC
    Int J STD AIDS; 2003 Sep; 14(9):644-5. PubMed ID: 14511507
    [No Abstract]   [Full Text] [Related]  

  • 17. Protect yourself from Pneumocystis carinii.
    AIDS Alert; 1999 Jun; 14(6):suppl 1-2. PubMed ID: 11366414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia.
    Kovacs JA; Gill VJ; Meshnick S; Masur H
    JAMA; 2001 Nov; 286(19):2450-60. PubMed ID: 11712941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discontinuing prophylaxis against Pneumocystis carinii pneumonia.
    Le Moal G; Breux JP; Roblot F
    N Engl J Med; 2001 May; 344(21):1639-41. PubMed ID: 11374363
    [No Abstract]   [Full Text] [Related]  

  • 20. Pneumocystis pneumonia.
    Robberts FJ; Chalkley LJ; Liebowitz LD
    SADJ; 2002 Dec; 57(11):451-3. PubMed ID: 12674864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.